Literature DB >> 574240

Lymphocyte-macrophage activity in the endolymphatic sac. An ultrastructural study of the rugose endolymphatic sac in the guinea pig.

H Rask-Andersen, J Stahle.   

Abstract

The irregular epithelial layer which delimits the intermediate part of the endolymphatic sac, and the surrounding perisaccular tissue, were examined morphologically in the guinea pig by transmission electron microscopy. Specialized areas of the epithelium which have previously been designated as "non-vascularized epithelial processes" (NVP) were constantly observed. These proliferative areas showed a close topographical relation to the free luminal cells and contained an abundance of lymphoid cells. Lymphocytes and macrophages were intimately associated with each other in a manner similar to that seen in these two types of cells in antigen-stimulated lymphoid tissues. There was a marked degeneration and phagocytosis of cells. The richly vascularized perisaccular tissue was rich in plasma cells, monocytes, mast cells and lymphocytes. The latter could be seen to migrate through the endothelial cells in the thin post-capillary venules into the sac tissue. The authors consider that the endolymphatic sac plays a role as an immunological defence organ for the internal ear. A hypothetical model concerning circulation and turnover of certain of the free intraluminal cells in presented.

Entities:  

Mesh:

Year:  1979        PMID: 574240     DOI: 10.1159/000275458

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  9 in total

1.  The endolymphatic duct and sac of the rat: a histological, ultrastructural, and immunocytochemical investigation.

Authors:  A Dahlmann; M von Düring
Journal:  Cell Tissue Res       Date:  1995-11       Impact factor: 5.249

2.  Proinflammatory cytokine expression in the endolymphatic sac during inner ear inflammation.

Authors:  Hitoshi Satoh; Gary S Firestein; Peter B Billings; Jeffrey P Harris; Elizabeth M Keithley
Journal:  J Assoc Res Otolaryngol       Date:  2003-06

Review 3.  Chronic inflammation - inflammaging - in the ageing cochlea: A novel target for future presbycusis therapy.

Authors:  Nathan Watson; Bo Ding; Xiaoxia Zhu; Robert D Frisina
Journal:  Ageing Res Rev       Date:  2017-10-07       Impact factor: 10.895

4.  A Micro-CT and Synchrotron Imaging Study of the Human Endolymphatic Duct with Special Reference to Endolymph Outflow and Meniere's Disease.

Authors:  Charlotta Kämpfe Nordström; Hao Li; Hanif M Ladak; Sumit Agrawal; Helge Rask-Andersen
Journal:  Sci Rep       Date:  2020-05-19       Impact factor: 4.379

5.  The Human Endolymphatic Sac and Inner Ear Immunity: Macrophage Interaction and Molecular Expression.

Authors:  Charlotta Kämpfe Nordström; Niklas Danckwardt-Lillieström; Göran Laurell; Wei Liu; Helge Rask-Andersen
Journal:  Front Immunol       Date:  2019-02-01       Impact factor: 7.561

6.  An Immunological Perspective to Non-syndromic Sensorineural Hearing Loss.

Authors:  K P Sindura; Moinak Banerjee
Journal:  Front Immunol       Date:  2019-12-11       Impact factor: 7.561

Review 7.  Cochlear Inflammaging in Relation to Ion Channels and Mitochondrial Functions.

Authors:  Parveen Bazard; Jennifer Pineros; Robert D Frisina; Mark A Bauer; Alejandro A Acosta; Lauren R Paganella; Dominika Borakiewicz; Mark Thivierge; Freyda L Mannering; Xiaoxia Zhu; Bo Ding
Journal:  Cells       Date:  2021-10-15       Impact factor: 6.600

8.  Vestibular Aqueduct Morphology and Meniere's Disease-Development of the "Vestibular Aqueduct Score" by 3D Analysis.

Authors:  Laurent Noyalet; Lukas Ilgen; Miriam Bürklein; Wafaa Shehata-Dieler; Johannes Taeger; Rudolf Hagen; Tilmann Neun; Simon Zabler; Daniel Althoff; Kristen Rak
Journal:  Front Surg       Date:  2022-02-04

Review 9.  Immune system of the inner ear as a novel therapeutic target for sensorineural hearing loss.

Authors:  Takayuki Okano
Journal:  Front Pharmacol       Date:  2014-09-02       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.